Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$148.84

-1.21 (-0.81%)

06:00
08/16/19
08/16
06:00
08/16/19
06:00

Nvidia price target lowered to $185 from $192 at Mizuho

Mizuho analyst Vijay Rakesh lowered his price target for Nvidia to $185 from $192 while maintaining a Buy rating on the shares following last night's Q2 results. The company reported an in-line July quarter and guided to a "better than feared" October quarter, Rakesh tells investors in a research note. With the stock up only 11% year-to-date, expectations into the quarter were low, contends the analyst.

  • 09

    Sep

NVDA Nvidia
$148.84

-1.21 (-0.81%)

08/13/19
08/13/19
INITIATION
Target $32

Hold
AMD initiated with a Hold at Loop Capital
As previously reported, Loop Capital analyst Cody Acree initiated AMD (AMD) with a Hold rating and a price target of $32. The analyst is positive on the company's "significant transformation" since 2016 that yielded an attractive growth rate and operational profitability, noting that while many of its latest next-generation platforms are just starting to come to market, early reviews indicate "impressive performance" against comparable offerings from Intel (INTC) and Nvidia (NVDA). Acree believes that AMD is "well positioned" to gain material market share across its primary target markets, but also sees the stock as "fairly valued".
08/13/19
RBCM
08/13/19
NO CHANGE
Target $190
RBCM
Outperform
Nvidia price target lowered to $190 from $200 at RBC Capital
RBC Capital analyst Mitch Steves lowers his price target on Nvidia to $190 ahead of its July quarter results, saying there is some downside risk to its data center estimates with the likelihood of in-line performance in its other segments. The analyst is keeping his Outperform rating however, noting he would take advantage of any pullback in Nvidia stock price if the company forecasts improvement in the data center environment. Steves adds that his price target revision mainly reflects the "geopolitical turmoil" rather than any changes in fundamentals.
08/14/19
SBSH
08/14/19
NO CHANGE
SBSH
Buy
Nvidia expectations for second half 'need one last reset,' says Citi
Citi analyst Atif Malik keeps a Buy rating on shares of Nvidia ahead of the company's July quarter results on August 15. Street expectations for the second half of 2019 "need one last reset" before the stock can work sustainably, Malik tells investors in a pre-earnings research note. The analyst models for year-over-year growth to resume in Nvidia's January quarter. He views 2019 as a "reset year" on cryptocurrency, China, and first half data center weakness. Malik expects "strong" 20% revenue growth to resume in 2020 for Nvidia.
08/15/19
JEFF
08/15/19
NO CHANGE
Target $210
JEFF
Buy
Investors want to buy Nvidia, will with any good news, says Jefferies
Jefferies analyst Mark Lipacis thinks investors want to buy shares of Nvidia and that "any whiff" of good data center news will likely drive the stock higher. The analyst has a "long-bias" on Nvidia heading into the Q2 report. He senses investor caution on the company's data center business in Q2. Data points from suppliers into data centers are mixed, but some are showing early signs of revival, Lipacis tells investors in a pre-earnings research note. Further, his channel checks indicate positive trends in PC gaming GPUs. The analyst keeps a Buy rating on Nvidia with a $210 price target.

TODAY'S FREE FLY STORIES

MYOV

Myovant Sciences

$7.81

0.83 (11.89%)

08:33
08/20/19
08/20
08:33
08/20/19
08:33
Hot Stocks
Myovant Sciences completes patient recruitment for Phase 3 SPIRIT 2 study »

Myovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$51.55

0.13 (0.25%)

08:33
08/20/19
08/20
08:33
08/20/19
08:33
Hot Stocks
TJX reports Q2 consolidated SSS up 2% »

Reports Q2 SSS at Marmaxx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$51.55

0.13 (0.25%)

08:31
08/20/19
08/20
08:31
08/20/19
08:31
Earnings
TJX reports Q2 adjusted EPS 62c, consensus 62c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

HRTX

Heron Therapeutics

$17.72

0.53 (3.08%)

08:31
08/20/19
08/20
08:31
08/20/19
08:31
Hot Stocks
Heron Therapeutics announces results from EPOCH 2 Phase 3 study of HTX-011 »

Heron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBNT

Ubiquiti

$110.62

0.23 (0.21%)

08:30
08/20/19
08/20
08:30
08/20/19
08:30
Options
One new option listing and one option delisting on August 20th »

New option listings for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPDW

Deep Down

$0.00

(0.00%)

08:29
08/20/19
08/20
08:29
08/20/19
08:29
Hot Stocks
Deep Down receives Kaikias Riser Isolation Valve system order »

Deep Down announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
08/20/19
08/20
08:29
08/20/19
08:29
Conference/Events
Seaport Global to hold a conference »

St. Louis Coal Conference…

RNET

RigNet

$7.58

0.22 (2.99%)

08:27
08/20/19
08/20
08:27
08/20/19
08:27
Hot Stocks
Ocyan signs multi-year agreement with RigNet for Intelie Live »

RigNet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

08:26
08/20/19
08/20
08:26
08/20/19
08:26
Recommendations
Sarepta analyst commentary  »

FDA's CRL on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMIA

Jumia Technologies

$15.45

2.31 (17.58%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Upgrade
Jumia Technologies rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Hot Stocks
Breaking Hot Stocks news story on Cancer Genetics »

Cancer Genetics says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Cancer Genetics reports Q2 cont. ops. EPS (1c) vs. (3c) last year »

Reports Q2 revenue $1.5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$104.15

1.42 (1.38%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Medtronic sees Q2 EPS $1.27-$1.29, consensus $1.28 »

Sees Q2 revenue similar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$6.70

0.29 (4.52%)

, ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Hot Stocks
Teva announces availability of EpiPen Jr generic equivalent »

Teva (TEVA) announced…

TEVA

Teva

$6.70

0.29 (4.52%)

ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IYT

iShares Transportation Average

$181.54

1.76 (0.98%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Conference/Events
Federal Reserve Board Vice Chairman participates in a panel discussion »

Federal Reserve Board of…

XLK

Technology Select Sector SPDR

$79.48

1.21 (1.55%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$58.30

1.25 (2.19%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$117.31

1.44 (1.24%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODP

Office Depot

$1.51

0.07 (4.86%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Recommendations
Office Depot analyst commentary  »

Office Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.05

0.42 (0.74%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$61.74

0.39 (0.64%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.